These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study. Llop CJ; Tuttle E; Tillotson GS; LaPlante K; File TM Hosp Pract (1995); 2017 Feb; 45(1):1-8. PubMed ID: 28064542 [TBL] [Abstract][Full Text] [Related]
7. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia. Weiss K; Tillotson GS Chest; 2005 Aug; 128(2):940-6. PubMed ID: 16100190 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459 [TBL] [Abstract][Full Text] [Related]
9. Appropriate outpatient macrolide use in community-acquired pneumonia. Gotfried MH J Am Acad Nurse Pract; 2004 Apr; 16(4):146, 148, 150 passim. PubMed ID: 15137473 [TBL] [Abstract][Full Text] [Related]
10. Principles of Antibiotic Management of Community-Acquired Pneumonia. Bender MT; Niederman MS Semin Respir Crit Care Med; 2016 Dec; 37(6):905-912. PubMed ID: 27960214 [TBL] [Abstract][Full Text] [Related]
11. Management of community-acquired pneumonia in adults. Working Group of the South African Thoracic Society S Afr Med J; 2002 Aug; 92(8 Pt 2):647-55. PubMed ID: 12244941 [TBL] [Abstract][Full Text] [Related]
12. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study. Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial therapy in community-acquired pneumonia among emergency patients in a university hospital in Japan. Kawai S; Ochi M; Nakagawa T; Goto H J Infect Chemother; 2004 Dec; 10(6):352-8. PubMed ID: 15614461 [TBL] [Abstract][Full Text] [Related]
15. Role of gemifloxacin in community-acquired pneumonia. Tillotson GS Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107 [TBL] [Abstract][Full Text] [Related]
19. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. Miyashita N; Fukano H; Mouri K; Fukuda M; Yoshida K; Kobashi Y; Niki Y; Oka M J Med Microbiol; 2005 Apr; 54(Pt 4):395-400. PubMed ID: 15770027 [TBL] [Abstract][Full Text] [Related]
20. The role of new therapies for severe community-acquired pneumonia. Restrepo MI; Anzueto A Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]